Common Contracts

ASSET PURCHASE AGREEMENT By and between AstraZeneca AB and Horizon Pharma USA, Inc. Dated as of November 18, 2013

Asset Purchase Agreement • May 23rd, 2014 • Horizon Pharma, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Asset Purchase Agreement
• Filed
  May 23rd, 2014
• Company
  Horizon Pharma, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Asset Purchase Agreement (this “Agreement”) is made and executed as of November 18, 2013 (the “Execution Date”), by and between AstraZeneca AB, a Swedish corporation (“AstraZeneca”), and Horizon Pharma USA, Inc., a Delaware corporation (“Horizon”). AstraZeneca and Horizon are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”

ASSET PURCHASE AGREEMENT By and between AstraZeneca AB and Horizon Pharma USA, Inc. Dated as of November 18, 2013

Asset Purchase Agreement • March 13th, 2014 • Horizon Pharma, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Asset Purchase Agreement
• Filed
  March 13th, 2014
• Company
  Horizon Pharma, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Asset Purchase Agreement (this “Agreement”) is made and executed as of November 18, 2013 (the “Execution Date”), by and between AstraZeneca AB, a Swedish corporation (“AstraZeneca”), and Horizon Pharma USA, Inc., a Delaware corporation (“Horizon”). AstraZeneca and Horizon are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”